PHARMACY IV ADMIXTURE. Pharmacy 483 January 17, 2006 Kim Donnelly Affiliate Associate Professor

Similar documents
PHARMACY IV ADMIXTURE

Baxa Corporation. Technical Paper. Environmental Controls for Sterile Compounding

Summary of USP* 797 Pharmaceutical Compounding Sterile Preparations

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts

UNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL CLEANROOMS

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

4.5 Compounding Compounding in Licensed Pharmacies.

Compounding Aseptic Isolators (CAI) James T Wagner

USP <797> Compliance Common Challenges and Potential Solutions

j) Direct and Contiguous Compounding Area refers to the specific area where a compound is prepared.

Guidelines for Design of. Compounded Sterile Products (CSPs) Facility

Enhanced Sterile Medication Compounding Evaluation

Sterile Compounding elearning Course Curriculum 28 lessons with 33 hours of CE. Fundamentals of Sterile Compounding (8 lessons/8 hours CE)

Pharmacy Quality Assurance Commission Sterile Compounding [USP <797>] Self-Assessment Compliance Checklist

QUALITY ASSURANCE & AUDIT

USP 797 & 800 Pharmacy Overview. (Presented to Vermont Chapter of New England Healthcare Engineers May 2016)

The ABCs and Challenges of GMP The American Experience

Pharmaceutical compounding standards. The minimum standards and technical equipment to be considered as adequate shall include: 1.

USP <797> and Environmental Sampling

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

STANDARDS FOR COMPOUNDING PHARMACIES

Facility Design for Pharmacy Operation. Full-Scale Nuclear. Slides are not to be reproduced without permission of author.

for IND and RDRC Regulated PET Compounding

Pharmacy Compounding: Infection Prevention

2008 USPC Official 5/1/08-7/31/08 General Chapters: <797> PHARMACEUTICAL... Page 1 of PHARMACEUTICAL COMPOUNDING STERILE PREPARATIONS

FLORIDA SOCIETY OF HEALTH SYSTEM PHARMACISTS NOVEMBER 4, 2016 JAMES T WAGNER CONTROLLED ENVIRONMENT CONSULTING

compounding area based on environmental sampling and cleaning product type. Antiseptics and determine the appropriate use of each.

Overview of a sterility assurance program for PET drugs

USP CHAPTER <797> INTRODUCTION RISK LEVELS

Tel: TTY: NOTICE OF PUBLIC HEARING

History and Update of Chapters 797 and 800

HardyVal TM CSP MEDIUM-RISK LEVEL MEDIA-FILL CHALLENGE KITS

ENFORCEMENT AND COMPOUNDING COMMITTEE REPORT June 2, 2017

MINIMUM REQUIREMENTS FOR A VENDOR

Who says you re competent?

Thanks and acknowledgement to Pamela Isaacs for the content and slides in this presentation.

Industry Perspective on PET Manufacturing Comparison of EU and US

Improving the Safety of Compounded Preparations - USP <800> Compliance in Every Day Practice

USP <800> A practical approach to compliance. Ryan W. Naseman, PharmD, MS, BCPS Michael Storey, PharmD, MS, BCPS

LUNCH AND LEARN. October 14, CE Activity Information & Accreditation

Pharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD

Community Pharmacy Opening/Renovation Audit

Infection and Intravenous Drug Delivery: A Long and Tumultuous Relationship

USP <797>/<800> Cleanroom Design & Environmental Monitoring. A presentation for HealthTrust Members November 14, 2018

USP Chapter <797> & <800> Testing Supplies

Re: Insanitary Conditions at Compounding Facilities, Guidance for Industry (Docket ID: FDA-2016-D )

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services

US Regulatory Requirements: Clinical & Clinical Research Production, SPECT & PET Radiopharmaceuticals (RPs)

BRIEFING 797 PHARMACEUTICAL COMPOUNDING STERILE PREPARATIONS INTRODUCTION

Developed and Presented by: Wisconsin Healthcare Engineering Association

LUNCH AND LEARN. September 11, CE Activity Information & Accreditation

USP <800> PRACTICAL COMPLIANCE STRATEGIES FOR ALL PRACTICE SETTINGS

Learning Objectives. What is a Compounding Pharmacist? Disclosure

2017 Diversion Specialists

CERTIFICATION REPORTS, WHAT DO I NEED TO KNOW?

Chapter WAC Compounding Practices Crosswalk

FDA s Guidance for Industry

CERTIFICATION REPORTS, WHAT DO I NEED TO KNOW?

PhEn-602 Notes # 4 J. Manfredi

QUALITY UPDATE Q1 2018

RE: IACP Comments MA Proposed 247 CMR Sterile Compounding Regulations

Standard Operating Procedure

HAZARDOUS MATERIALS 7/7/2016 OR THE RIGHT-TO-KNOW HAZARD COMMUNICATION STANDARD (HCS) DISCLAIMER

Compounding Questions and Answers

Microbiology Testing: USP requirements for Sterile and Nonsterile Preparations Webinar Q&A

CAPS 503B Pharmacy cgmp Compliance

POLICY Title: Surface Wipe Sampling Number: V-50 Effective Date: Revision Date:

Environmental Monitoring of Aseptic Processing Areas - 1

Position: Sr. Director of Education and Data - NHIA, VP of Research - NHIF

1972: Founded to manufacture laminar flow cabinets and design and build cleanrooms

Hospital Pharmacy Isolator Solutions for USP <797> Compliance from Esco

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

Infection Prevention for Pharmacy Compounding

This compilation of the complex

Full Contact Details:

Overview of Inspection Issues with Legacy Products. Barbara Breithaupt Consumer Safety Officer

PRESENTED BY JUNE 17, 2016 LOS ANGELES, CALIFORNIA UCLA

PHCT 401 Aseptic Processes & Techniques

á797ñ PHARMACEUTICAL COMPOUNDING STERILE PREPARATIONS

How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant

STONEHILL COLLEGE. Lab Inspection Checklist

BIO & PHARMA ANALYTICAL TECHNIQUES

Sterile Compounding Safety

Ghalib Abbasi, RPh, MS, PharmD Pharmacy Technology Consultant Florida, USA

Important Updates in USP <797> and USP <823> Eric S. Kastango, MBA, BS Pharm, FASHP Clinical IQ, LLC & CriticalPoint, LLC Madison, New Jersey

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

Study Summary. Results: All tested media-filled vials were negative for growth of any microorganisms.

MSC Expansion Medium for Bone Marrow Derived MSCs Kit Culture

Pharmacy Quality Assurance Self-Assessment (Non -Sterile Compounding Hazardous and Non Hazardous)

USP<800> A Deeper Dive. Joe Cabaleiro R.Ph.

LUNCH AND LEARN. Current Regulatory Landscape for Sterile Compounding: Part 1. June 8, 2018

Proposed Revision of USP General Chapter Radiopharmaceuticals for Positron Emission Tomography Compounding <823>

Survey of Sterile Admixture Practices in Canadian Hospital Pharmacies: Part 2. More Results and Discussion

Animal Facility Biosafety Level 3 Checklist (date: April 16, 1998)

BRIEFING 797 Pharmaceutical Compounding Sterile Preparations,

Asbestos in the Workplace: A Guide to Removal of Friable Asbestos Containing Materials

Microbiological Consideration for Non-Sterile Pharmaceutical

Inspection Form. DPP Information. Inspection Information. Staff Information. Service Information. DPP Designated Member. Street City Postal Code

Environmental Monitoring of Aseptic Processing Areas - 2

Guidance. Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE

Transcription:

PHARMACY IV ADMIXTURE Pharmacy 483 January 17, 2006 Kim Donnelly Affiliate Associate Professor

Pharmacist is responsible for ensuring that compounded sterile preparations are properly prepared, labeled, stored, dispensed and delivered. USP ASHP NABP JCAHO

Centralized IV Admixture Service Economical Batch preparation Reduce personnel time Enhanced safety with standardized solutions. Double check process on all prepared solutions. Cleaner, more controlled environment.

USP-797 New standards effective Jan 2004 Standards will be enforced by Boards of Pharmacy. Sterile product preparations are categorized as high, medium or low risk preparations based on the potential for microbial, chemical and physical contamination.

Buffer Room Must be ISO Class 7 (Class 10,000) Prepared in a ISO Class 5 (Class 100) laminar airflow workbench Positive pressure room with HEPA filtered air. Access is restricted in Buffer area.

ISO Class 7 Also referred to as a Class 10,000 environment. Air particle count does not exceed 10,000 particles 0.5 microns or larger per cubic foot of air.

Buffer Rooms Walls, floors, ceiling should be smooth, no cracks and crevices. Ceilings should be sealed. Floors coved. No sinks in Buffer area. Only non-shedding paper products in area.

Ante-Room or Ante-Area Gowning and hand-washing. No food or beverages. No carts moving back and forth from buffer zone to ante-area. Wipe down of products before introducing into the buffer area.

Laminar Flow Hoods Horizontal Vertical Barrier Isolators Certified every 6 mo. ISO Class 5 (Class 100) environment.

Gowning Remove make-up, jewelry. Scrub hands and arms to elbow. Non-shedding gown, knee length with a zip or snap front. Shoe covers, hair covers, face mask and gloves.

Risk Classification Low-Risk Compounding Medium-Risk Compounding High-Risk Compounding Simple admixtures using closed system transfer methods. Admixtures using multiple additives or batch preparations. Non-sterile ingredients or open-system transfers.

Beyond-Use Dating Storage period before administration. When compounded sterile products are stored for prolonged periods of time there is potential for microbial growth and pyrogen formation. Chemical stability Microbial sterility

Beyond-Use Dating Risk Level Room Temp Refrigeration Freezer Low 48 hrs 14 days 45 days Medium 30 hrs 9 days 45 days High 24 hrs 3 days 45 days

Personnel Documented education, training and competency. Didactic training. Competency tests. Return demonstration/observation. Media-fill testing of aseptic manipulative skills.

Media-fill test kit

Media-fill challenge testing Sterile bacterial culture medium transferred via a variety of aseptic manipulations Test should represent the most challenging products made for a particular risk level Products are monitored for microbial growth, indicated by visual turbidity, for 14 days Done annually and for new employees

Environmental Controls and Testing Routine cleaning schedule. Laminar flow hood certification every 6 months. Particle-count testing. Electric air samplers or agar settling plates.

Total Parenteral Nutrition Multiple ingredients (1-3 liters). Standard Operating Procedures. Automated Compounders Improve accuracy and efficiency. Accuracy verified by weight, volume.

Hazardous Drugs NIOSH (National Institute for Occupational Safety and Health) Guidelines. Vertical flow hood vented to the outside to protect operator. Pharmacy attaches tubing to reduce RN exposure. Negative pressure room. Separate storage/receiving procedures.

Resources United States Pharmacopeia (USP) web site: www.usp.org American Society of Health-System Pharmacists (ASHP) web site: www.ashp.org Kastango ES, Bradshaw BD. USP chapter 797: Establishing a practice standard for compounding sterile preparations in pharmacy. Am J Health- Syst Pharm. 2004; 61:1928-1938.